BackFulcrum Therapeutics Overview
Fulcrum Therapeutics Inc

Fulcrum Therapeutics Target Price

See how FULC's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.74

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-06-02H.C. WainwrightAndrew Fein$319.8% downsideOpen
2026-06-02Jefferies$47% upsideOpen
2026-06-02Leerink Partners$47% upsideOpen
2026-06-02Truist FinancialGregory Renza$47% upsideOpen
2026-06-02Piper Sandler$319.8% downsideOpen
2026-02-24Truist FinancialGregory Renza$17354.5% upsideOpen
2025-12-11Truist Financial$18381.3% upsideOpen
2025-12-08Stifel Nicolaus$25568.4% upsideOpen
2025-12-08Cantor FitzgeraldKristen Kluska$24541.7% upsideOpen
2025-12-08RBC Capital$10167.4% upsideOpen
2025-12-08Piper Sandler$23515% upsideOpen
2025-12-08H.C. Wainwright$25568.4% upsideOpen
2025-11-24Truist Financial$14274.3% upsideOpen
2025-11-24H.C. WainwrightAndrew Fein$18381.3% upsideOpen
2025-10-30Piper Sandler$16327.8% upsideOpen
2025-10-21Leerink Partners$20434.8% upsideOpen
2025-07-29H.C. Wainwright$12220.9% upsideOpen
2025-05-29Piper SandlerEdward Tenthoff$9140.6% upsideOpen
2025-05-23Leerink PartnersJoseph Schwartz$12220.9% upsideOpen
2024-09-13H.C. WainwrightAndrew Fein$47% upsideOpen
2024-09-12RBC CapitalGregory Renza$47% upsideOpen
2024-09-12Stifel NicolausDae Gon Ha downgraded Fulcrum Therapeutics$319.8% downsideOpen
2024-09-12Bank of America SecuritiesTazeen Ahmad$246.5% downsideOpen
2024-09-09Bank of America SecuritiesTazeen Ahmad$10167.4% upsideOpen
2024-09-03RBC CapitalGregory Renza$15301.1% upsideOpen
2024-05-20Cantor FitzgeraldKristen Kluska$23515% upsideOpen
2024-05-13Goldman SachsCorinne Jenkins$15301.1% upsideOpen
2024-05-13Stifel NicolausDae Gon Ha$22488.2% upsideOpen
2024-03-13RBC CapitalGregory Renza$14274.3% upsideOpen
2022-11-15Goldman Sachs$11194.1% upsideOpen
2022-11-08Piper SandlerEdward Tenthoff$18381.3% upsideOpen

Fulcrum Therapeutics (FULC) FAQ

Stockcircle tracks target price for Fulcrum Therapeutics (FULC), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Fulcrum Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main FULC overview so you can move from this figure to the surrounding analysis quickly.